Chronic Myeloid Leukemia News

Latest Chronic Myeloid Leukemia News

Sun, 01 Nov 2009 14:59:38 +0100

Latest news for Chronic Myeloid Leukemia updated every 30 minutes, dedicated for patients, caregivers, physicians and researchers whose interest are chronic myeloid leukemia, chronic myelogenous leukemia, cml, leukemia, chronic.

Cancer Detection Lab Tests Online

Sun, 01 Nov 2009 14:59:38 +0100

Order cancer detection lab tests online safely and securely. Physicians Order Included. Always Secure. - Read more ...

Leukemia Ribbon

Sun, 01 Nov 2009 14:59:38 +0100

Leukemia Support Ribbon Lapel Pins. - Made in U.S.A. - Help Increase Leukemia Awareness and Early Detection.

The chronic leukemias of myeloid origin.

Chronic leukemias of myeloid origin disorders are the second major category of chronic leukemias. The first major category of chronic leukemias, leukemias of lymphoid origin, was discussed in part one of this two-part series . This group of neoplastic disorders ...

Chronic Myeloid Leukemia - Gleevec resistance is opening a market for synergistic use.

M2 PRESSWIRE-18 February 2003-Research and Markets: Chronic Myeloid Leukemia - Gleevec resistance is opening a market for synergistic use1994-2003 M2 COMMUNICATIONS LTD RDATE:02152003 With CML`s relatively low prevalence, the potential market for drugs launched for this indication historically ...

Researchers at Korea University, Medical Department have published new data on chronic myeloid leukemia.

According to a study from Seoul, South Korea, "To gain insight into the differential mechanism of gene promoter hypermethylation in acute and chronic leukemia, we identified the methylation status on one part of 5'CpG rich region of 8 genes, DAB2IP, DLC-1, H-cadherin, 04, Integrin alpha 4, RUNX3, ...

New chronic myeloid leukemia data have been reported by R. Santachiara and co-authors.

"Imatinib mesylate is a tyrosine kinase inhibitor used as first line treatment in chronic myeloid leukemia and gastrointestinal stromal tumorpatients. Although several in vitro and animal studies demonstrated that imatinib affects immune response, few immune alterations are described in humans," ...

Chronic Myeloid Leukemia: Diagnosis and Treatment

Chronic myeloid leukemia has become a model in research and management among malignant disorders. Since the discovery of the presence of a unique and constant chromosomal abnormality slightly more than 40 years ago, substantial progress has been made in the understanding of the biology of the ...

Investigators at Eberhard-Karls University, Institute of Pathology have published new data on chronic myeloid leukemia genetics.

Investigators publish new data in the report 'Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm.' "Atypical chronic myeloid leukemia as defined by the WHO classification is a rare hematopoietic stem cell disorder, which shows both ...

New chronic myeloid leukemia prognosis data have been reported by scientists at University of Texas, M. D. Anderson Cancer Center.

New investigation results, 'Molecular monitoring in chronic myeloid leukemia: response to tyrosine kinase inhibitors and prognostic implications,' are detailed in a study published in and lt;i and gt;Cancer and lt;/i and gt;. According to recent research published in the journal and lt;i and gt;Cancer and lt;/i and gt;, The ...

Research from University of California yields new findings on chronic myeloid leukemia genetics.

Investigators publish new data in the report 'Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia.' "Acute megakaryocytic leukemia is a rare form of acute myelogenous leukemia and may occur either de novo or by transformation of a preexisting myelodysplastic or ...

Reports outline chronic myeloid leukemia study findings from St. Orsola-Malpighi University.

" Imatinib mesylate is the first line treatment for chronic myeloid leukemia. The advent of imatinib increased survival significantly in patients in an advanced phase of the disease," scientists writing in the Haematologica - the Hematology Journal report . ...

New chronic myeloid leukemia therapy study findings have been reported by scientists at University of Massachusetts, Division of Hematology.

Current study results from the report, 'beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia,' have been published. According to a study from the United States, "Philadelphia chromosome-positive (Ph ...

Cancer Supplements

Sun, 01 Nov 2009 14:59:38 +0100

Discount Natural Cancer Supplements and Products and natural vitamin supplements at 20% to 70% off retail. Read more ...